Nuvonis Technologies

Activities: Pharmaceutical

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Inhaled therapies advance as clinical trial data signal progress on two respiratory fronts Two separate clinical programmes have reported encouraging progress in the development of inhaled therapies for respiratory conditions, with positive data emerging from trials...
  2. Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business The purchase will hand the Group a biologics drug substance manufacturing facility and a warehousing centre in Maryland, which Bora plans to use in cooperation with Tanvex...
  3. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with...
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Reaching resilience: why pharmaceutical manufacturing needs battery energy storage systems In a fast-changing energy landscape, Steve Ennis, Manufacturing Sector Manager for Aggreko, discusses the potential for battery energy storage systems (BESS) to address grid...
  5. The impact of Brexit on raw materials testing for the pharmaceutical industry (2026 update) Since the UK departed from the EU, the pharmaceutical regulatory landscape has undergone significant and lasting change; whereas early uncertainty has largely subsided, the...

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

Related Content

Research & Development

Naobios, Nuvonis and the European Vaccine Initiative collaborate to manufacture influenza challenge agent

Working with the Inno4Vac consortium, Naobios will leverage Nuvonis’s Vero Cell Bank to support the development of a controlled human infection model based on the influenza virus A(H3N2)
Manufacturing

BIA Separations and Nuvonis Technologies partner

The agreement between the two companies will aim to strengthen upstream and downstream process development in vaccine and gene therapy production
Subscribe now